Provided by Tiger Fintech (Singapore) Pte. Ltd.

Foghorn Therapeutics Inc.

4.59
+0.13002.91%
Post-market: 4.590.00000.00%19:06 EDT
Volume:73.86K
Turnover:329.83K
Market Cap:255.85M
PE:-3.42
High:4.62
Open:4.56
Low:4.32
Close:4.46
Loading ...
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 18, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 04, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Major Issues Report

8-K - Current report
Oct 29, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 27, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 20, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 20, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 19, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Oct 09, 2020

Correspondence

CORRESP [Cover] - Correspondence